Suchergebnisse - "Mertens, Daniel"

PubPharm (7)

1

Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax

enthalten in: Blood | 2020

von Tausch, E. | Schneider, C. | Robrecht, S. | +21

CommentIn: Blood. 2020 Jun 25;135(26):2333-2334. - PMID 32585022

2

Telomere length in mantle cell lymphoma

enthalten in: Blood | 2013

von Jebaraj, B. | Kienle, D. | Lechel, A. | +9

3

High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations

enthalten in: Blood | 2012

von Edelmann, J. | Holzmann, K. | Miller, F. | +19

4

Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Claus, R. | Lucas, D. | Stilgenbauer, S. | +17

5

Genetics of chronic lymphocytic leukemia

enthalten in: Clinics in laboratory medicine | 2011

von Schnaiter, A. | Mertens, D. | Stilgenbauer, S.

6

Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes

enthalten in: Blood | 2006

von Kienle, D. | Benner, A. | Kröber, A. | +8

7

Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2005

von Kienle, D. | Korz, C. | Hosch, B. | +8

1
[1]